Healthcare Analysts, along with Professor George Schett, discuss (relevant companies ACET, ALLO, SANA, KYTX RNAC, ARTV, CABA and CRSP) CAR-T in Autoimmune Diseases on an Analyst/Industry conference call to be held on July 30.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACET:
- Adicet Bio’s ADI-270 Gets FDA Fast Track for Cancer Therapy
- Adicet Bio gets fast track designation for ADI-270 to treat ccRCC
- Adicet Bio Advances with FDA Clearance and Upcoming Trial
- Adicet Bio announces FDA clearance of IND application for ADI-270
- Adicet Bio Shareholders Shape Future with Strategic Votes